Clinical trials
Recruiting Phase 3 trials in Estonia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 2 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 2 |
| 2025 | 15 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 36 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| Boehringer Ingelheim | 3 |
| Stichting Hemato-Oncologie voor Volwassenen Nederland | 3 |
| ETOP IBCSG Partners Foundation | 2 |
| Merck Sharp & Dohme LLC | 2 |
| Neurocrine Biosciences | 2 |
| Takeda | 2 |
| Zenas BioPharma (USA), LLC | 2 |
| argenx | 2 |
| Amgen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myeloid, Acute | 4 |
| Chickenpox | 3 |
| Multiple Sclerosis, Chronic Progressive | 3 |
| Arthritis, Psoriatic | 2 |
| COVID-19 | 2 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Community-Acquired Pneumonia | 2 |
| Major Depressive Disorder | 2 |
| Pneumonia | 2 |
| Polyradiculoneuropathy, Chronic Inflammatory Demyelinating | 2 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.